{"name": "Esperion Therapeutics",
 "permalink": "esperion-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/esperion-therapeutics",
 "homepage_url": "http://www.esperion.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Esperion",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "pharmaceutical, therapeutics, metabolic, medical, esperion, disease, products, treatment, healthcare, cardiovascular",
 "alias_list": "",
 "email_address": "",
 "phone_number": "734-332-0506",
 "description": "Treatment of cardiometabolic disease",
 "created_at": "Thu Jun 04 06:56:59 UTC 2009",
 "updated_at": "Mon Jun 03 03:32:07 UTC 2013",
 "overview": "\u003Cp\u003EEsperion Therapeutics, Inc. discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called \u0026#8220;HDL Therapy,\u0026#8221; which is based on the Company\u0026#8217;s understanding of high-density lipoprotein, or HDL, function.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       65],
      "assets/images/resized/0004/6610/46610v2-max-150x150.jpg"],
     [[250,
       109],
      "assets/images/resized/0004/6610/46610v2-max-250x250.jpg"],
     [[318,
       139],
      "assets/images/resized/0004/6610/46610v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder \u0026 President \u0026 CEO \u0026 Executive Chairman",
    "person":
     {"first_name": "Roger",
      "last_name": "S. Newton",
      "permalink": "roger-s-newton",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0004/6611/46611v1-max-150x150.png"],
          [[181,
            221],
           "assets/images/resized/0004/6611/46611v1-max-250x250.png"],
          [[181,
            221],
           "assets/images/resized/0004/6611/46611v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President \u0026 CEO \u0026 Board Member",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "VP, Business Development",
    "person":
     {"first_name": "Troy",
      "last_name": "Ignelzi",
      "permalink": "troy-ignelzi",
      "image": null}},
   {"is_past": false,
    "title": "CMO",
    "person":
     {"first_name": "Noah",
      "last_name": "Rosenberg",
      "permalink": "noah-rosenberg",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Nicole",
      "last_name": "Vitullo",
      "permalink": "nicole-vitullo",
      "image":
       {"available_sizes":
         [[[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-150x150.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-250x250.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Dan",
      "last_name": "Janney",
      "permalink": "dan-janney",
      "image":
       {"available_sizes":
         [[[108,
            150],
           "assets/images/resized/0026/7115/267115v1-max-150x150.jpg"],
          [[144,
            200],
           "assets/images/resized/0026/7115/267115v1-max-250x250.jpg"],
          [[144,
            200],
           "assets/images/resized/0026/7115/267115v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Patrick",
      "last_name": "Enright",
      "permalink": "patrick-enright",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Dov",
      "last_name": "Goldstein",
      "permalink": "dov-goldstein",
      "image":
       {"available_sizes":
         [[[95,
            144],
           "assets/images/resized/0026/7114/267114v1-max-150x150.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/7114/267114v1-max-250x250.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/7114/267114v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Louis",
      "last_name": "Lange",
      "permalink": "louis-lange",
      "image":
       {"available_sizes":
         [[[150,
            99],
           "assets/images/resized/0026/7118/267118v1-max-150x150.jpg"],
          [[248,
            165],
           "assets/images/resized/0026/7118/267118v1-max-250x250.jpg"],
          [[248,
            165],
           "assets/images/resized/0026/7118/267118v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "COO\u0026 CFO",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Member Of The Board Of Directors",
    "person":
     {"first_name": "Ronald",
      "last_name": "M. Cresswell",
      "permalink": "ronald-m-cresswell",
      "image":
       {"available_sizes":
         [[[110,
            121],
           "assets/images/resized/0025/5789/255789v1-max-150x150.jpg"],
          [[110,
            121],
           "assets/images/resized/0025/5789/255789v1-max-250x250.jpg"],
          [[110,
            121],
           "assets/images/resized/0025/5789/255789v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "Roger",
      "last_name": "S. Newton",
      "permalink": "roger-s-newton",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0004/6611/46611v1-max-150x150.png"],
          [[181,
            221],
           "assets/images/resized/0004/6611/46611v1-max-250x250.png"],
          [[181,
            221],
           "assets/images/resized/0004/6611/46611v1-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$55.8M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.esperion.com/modules/news/article.php?storyid=1",
    "source_description": "Esperion Therapeutics Completes $22.75M Series A Financing",
    "raised_amount": 22750000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 5,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Arboretum Ventures",
         "permalink": "arboretum-ventures",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6621/46621v1-max-150x150.png"],
             [[151,
               61],
              "assets/images/resized/0004/6621/46621v1-max-250x250.png"],
             [[151,
               61],
              "assets/images/resized/0004/6621/46621v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.businesswire.com/news/home/20130425005333/en/Esperion-Therapeutics-Completes-33-Million-Preferred-Financing",
    "source_description": "Esperion Therapeutics Completes $33 Million Preferred Financing to Advance Its Novel Oral LDL-C Lowering Therapy to Later Stage Clinical Trials",
    "raised_amount": 33000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Longitude Capital",
         "permalink": "longitude-capital",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/0126/60126v1-max-150x150.jpg"],
             [[237,
               64],
              "assets/images/resized/0006/0126/60126v1-max-250x250.jpg"],
             [[237,
               64],
              "assets/images/resized/0006/0126/60126v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Arboretum Ventures",
         "permalink": "arboretum-ventures",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6621/46621v1-max-150x150.png"],
             [[151,
               61],
              "assets/images/resized/0004/6621/46621v1-max-250x250.png"],
             [[151,
               61],
              "assets/images/resized/0004/6621/46621v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Company",
         "permalink": "asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0001/9262/19262v1-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0001/9262/19262v1-max-250x250.png"],
             [[377,
               62],
              "assets/images/resized/0001/9262/19262v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Ventures",
         "permalink": "asset-management-ventures",
         "image":
          {"available_sizes":
            [[[150,
               11],
              "assets/images/resized/0026/8869/268869v2-max-150x150.jpg"],
             [[250,
               19],
              "assets/images/resized/0026/8869/268869v2-max-250x250.jpg"],
             [[450,
               35],
              "assets/images/resized/0026/8869/268869v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "46701 Commerce Center Drive",
    "address2": "",
    "zip_code": "48170",
    "city": "Plymouth",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": 42.3853985,
    "longitude": -83.5069834}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:ESPR"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0004/6609/46609v1-max-150x150.jpg"],
      [[250,
        134],
       "assets/images/resized/0004/6609/46609v1-max-250x250.jpg"],
      [[450,
        242],
       "assets/images/resized/0004/6609/46609v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}